Matthew A. Spear - Net Worth and Insider Trading

Matthew A. Spear Net Worth

The estimated net worth of Matthew A. Spear is at least $111,595 dollars as of 2024-06-09. Matthew A. Spear is the Chief Medical Officer of Poseida Therapeutics Inc and owns about 41,485 shares of Poseida Therapeutics Inc (PSTX) stock worth over $111,595. Details can be seen in Matthew A. Spear's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Matthew A. Spear has not made any transactions after 2021-08-20 and currently still holds the listed stock(s).

Transaction Summary of Matthew A. Spear

To

Matthew A. Spear Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matthew A. Spear owns 1 companies in total, including Poseida Therapeutics Inc (PSTX) .

Click here to see the complete history of Matthew A. Spear’s form 4 insider trades.

Insider Ownership Summary of Matthew A. Spear

Ticker Comapny Transaction Date Type of Owner
PSTX Poseida Therapeutics Inc 2021-08-20 Chief Medical Officer

Matthew A. Spear Latest Holdings Summary

Matthew A. Spear currently owns a total of 1 stock. Matthew A. Spear owns 41,485 shares of Poseida Therapeutics Inc (PSTX) as of August 20, 2021, with a value of $111,595.

Latest Holdings of Matthew A. Spear

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PSTX Poseida Therapeutics Inc 2021-08-20 41,485 2.69 111,595

Holding Weightings of Matthew A. Spear


Matthew A. Spear Form 4 Trading Tracker

According to the SEC Form 4 filings, Matthew A. Spear has made a total of 3 transactions in Poseida Therapeutics Inc (PSTX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Poseida Therapeutics Inc is the sale of 4,000 shares on August 20, 2021, which brought Matthew A. Spear around $35,160.

Insider Trading History of Matthew A. Spear

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Matthew A. Spear Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Matthew A. Spear Ownership Network

Ownership Network List of Matthew A. Spear

No Data

Ownership Network Relation of Matthew A. Spear

Insider Network Chart

Matthew A. Spear Owned Company Details

What does Poseida Therapeutics Inc do?

Who are the key executives at Poseida Therapeutics Inc?

Matthew A. Spear is the Chief Medical Officer of Poseida Therapeutics Inc. Other key executives at Poseida Therapeutics Inc include President & Cell Therapy Kristin Yarema , 10 percent owner Malin Life Sciences Holdings Ltd , and director & 10 percent owner & Chief Executive Officer Eric Ostertag .

Poseida Therapeutics Inc (PSTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Poseida Therapeutics Inc (PSTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Poseida Therapeutics Inc (PSTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Poseida Therapeutics Inc (PSTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Poseida Therapeutics Inc Insider Transactions

No Available Data

Matthew A. Spear Mailing Address

Above is the net worth, insider trading, and ownership report for Matthew A. Spear. You might contact Matthew A. Spear via mailing address: C/o Poseida Therapeutics, Inc., 4242 Campus Point Court, Suite 700, San Diego Ca 92121.

Discussions on Matthew A. Spear

No discussions yet.